The One Where We Talk About Hep A and Community Immunity

Impossibile aggiungere al carrello

Puoi avere soltanto 50 titoli nel carrello per il checkout.

Riprova più tardi

Rimozione dalla Lista desideri non riuscita.

Riprova più tardi

Non è stato possibile aggiungere il titolo alla Libreria

Per favore riprova

Non è stato possibile seguire il Podcast

Per favore riprova

Esecuzione del comando Non seguire più non riuscita

The One Where We Talk About Hep A and Community Immunity

Ascolta gratuitamente

Vedi i dettagli del titolo

A proposito di questo titolo

Division of Viral Hepatitis. Hepatitis Surveillance Report - United States, 2011. United States Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA 2011. Daniels D, Grytdal S, Wasley A, Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis - United States, 2007. MMWR Surveill Summ 2009; 58:1.Hadler SC, Webster HM, Erben JJ, et al. Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med 1980; 302:1222.Vernon AA, Schable C, Francis D. A large outbreak of hepatitis A in a day-care center: association with non-toilet-trained children and persistence of IgM antibody to hepatitis A virus. Am J Epidemiol 1982; 115:325.Tong MJ, el-Farra NS, Grew MI. Clinical manifestations of hepatitis A: recent experience in a community teaching hospital. J Infect Dis 1995; 171 Suppl 1:S15.Centers for Disease Control and Prevention. Hepatitis Surveillance Report. United States Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA 2011. 7.World Health Organization . Hepatitis A - fact sheet 2019. 2019. [accessed 2019 December20]. https://www.who.int/news-room/fact-sheets/detail/hepatitis-a. 8.World Health Organization . Global health sector strategy on viral hepatitis, 2016–2021 Geneva: World Health Organization; 2016. June [accessed 2019 December20]. http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf?ua=1. Link-Gelles R, Hofmeister MG, Nelson NP. Use of hepatitis A vaccine for post-exposure prophylaxis in individuals over 40 years of age: A systematic review of published studies and recommendations for vaccine use. Vaccine. 2018;36(20):2745–50.doi: 10.1016/j.vaccine.2018.04.015. .Dhankhar P, Nwankwo C, Pillsbury M, Lauschke A, Goveia MG, Acosta CJ, Elbasha EH. Public health impact and cost-effectiveness of hepatitis A vaccination in the United States: a disease transmission dynamic modeling approach. Value Health. 2015;18(4):358–67. doi: 10.1016/j.jval.2015.02.004. https://my.clevelandclinic.org/health/articles/22599-herd-immunity?utm_source=join1440&utm_medium=email&utm_placement=newsletter&user_id=66c4bce35d78644b3a99e621https://onech-my.sharepoint.com/:w:/r/personal/smithj_onecommunityhealth_org/_layouts/15/Doc.aspx?sourcedoc=%7B25810DE8-2910-43D0-9634-B1DDDD87FA61%7D&file=Podcast%2024%20Hepatitis%20A.docx&fromShare=true&action=default&mobileredirect=truehttps://onech-my.sharepoint.com/:w:/r/personal/smithj_onecommunityhealth_org/_layouts/15/Doc.aspx?sourcedoc=%7B25810DE8-2910-43D0-9634-B1DDDD87FA61%7D&file=Podcast%2024%20Hepatitis%20A.docx&fromShare=true&action=default&mobileredirect=truehttps://onech-my.sharepoint.com/:w:/r/personal/smithj_onecommunityhealth_org/_layouts/15/Doc.aspx?sourcedoc=%7B25810DE8-2910-43D0-9634-B1DDDD87FA61%7D&file=Podcast%2024%20Hepatitis%20A.docx&fromShare=true&action=default&mobileredirect=true 15. www.boostoregon.org Submit a topic request: https://forms.monday.com/forms/659b439e15af3c32cd423e42df124213?r=use1Visit our website: https://www.onecommunityhealth.org/Follow us on Instagram: https://www.instagram.com/onecommunitygorge/Sign Up for Our Newsletter: https://lp.constantcontactpages.com/sl/H2LsqnN

Ancora nessuna recensione